Patents by Inventor Jorge R. Vila

Jorge R. Vila has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
    Patent number: 6093702
    Abstract: A method and composition for inhibiting the spread of a retrovirus such as HIV in a human cell population in which a retrovirus such as HIV is present has been found. The spread of the retrovirus is inhibited by treatment of the cells with a synergistic combination mixture of a dideoxy-ribonucleoside excluding AZT and hydroxycarbamide.
    Type: Grant
    Filed: March 8, 1995
    Date of Patent: July 25, 2000
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Serge D. Malley, Jorge R. Vila
  • Method of treating HIV in humans by administration of ddI and hydroxycarbamide
    Patent number: 5736527
    Abstract: A method and composition for inhibiting the spread of a retrovirus such as HIV in a human cell population in which a retrovirus such as HIV is present has been found. The spread of the retrovirus is inhibited by treatment of the cells with a synergistic combination mixture of a dideoxy-ribonucleoside excluding AZT and hydroxycarbamide.
    Type: Grant
    Filed: March 18, 1996
    Date of Patent: April 7, 1998
    Assignee: Compagnie de Developpment Aguettant S.A.
    Inventors: Serge D. Malley, Jorge R. Vila
  • Mixtures of DDI and D4T with hydroxycarbamide for inhibiting retroviral replication
    Patent number: 5736526
    Abstract: A method and composition for inhibiting the spread of a retrovirus such as HIV in a human cell population in which a retrovirus such as HIV is present has been found. The spread of the retrovirus is inhibited by treatment of the cells with a synergistic combination mixture of a dideoxy-ribonucleoside excluding AZT and hydroxycarbamide.
    Type: Grant
    Filed: December 22, 1995
    Date of Patent: April 7, 1998
    Assignee: Compagnie de Development Aguettant S.A.
    Inventors: Serge D. Malley, Jorge R. Vila
  • Method of treating HIV in humans by administration of ddI and hydroxycarbamide
    Patent number: 5521161
    Abstract: A method and composition for inhibiting the spread of a retrovirus such as HIV in a human cell population in which a retrovirus such as HIV is present has been found. The spread of the retrovirus is inhibited by treatment of the cells with a synergistic combination mixture of a dideoxy-ribonucleoside excluding AZT and hydroxycarbamide.
    Type: Grant
    Filed: December 20, 1993
    Date of Patent: May 28, 1996
    Assignee: Compagnie de Developpment Aguettant S.A.
    Inventors: Serge D. Malley, Jorge R. Vila